Ermenegildo Zegna NV
ZGN
12.19
-0.31
-2.48%
Ermenegildo Zegna NV
US · ZGN
#2069 by market cap
Listed 1970
12.19
-0.31
-2.48%
Live - 5344 symbols - heartbeat 471s ago
· 2026-10-08 04:00
Pre-market
12.19
0.00%
After-hours
12.19
0.00%
Overnight
12.53
+2.79%
- Market cap
- 3.28B
- P/E (TTM)i
- 36.28
- P/Bi
- 2.82
- EPSi
- 0.43
- Div yieldi
- 1.12%
- 52W posi
- 49%
Reader sentiment
Are you bullish or bearish on ZGN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.52, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -1.53% YoY
Margins
- Gross margin
- 67.51%
- Operating margin
- 7.28%
- Net margin
- 5.14%
Key ratios & quality
- Enterprise valuei
- 3.37B
- PEG ratioi
- 1.50
- Altman Z-Scorei
- 2.52
PEG uses trailing P/E against the 3-year net income growth rate (24.18%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.18B | 1.32B | 1.01B | 1.29B | 1.49B | 1.90B | 1.95B | 1.92B |
| Gross profit | 606.56M | 639.83M | 477.24M | 796.70M | 928.01M | 1.22B | 1.30B | 1.29B |
| Selling & admin expenses | 321.97M | 333.45M | 284.56M | 890.73M | 780.23M | 1.02B | 1.13B | 1.15B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 103.27M | 108.10M | 11.05M | -94.03M | 147.78M | 208.15M | 166.85M | 139.48M |
| Pretax profit | 69.91M | 69.23M | -31.56M | -96.96M | 101.08M | 169.09M | 130.61M | 140.04M |
| Tax | 29.40M | 43.79M | 14.98M | 30.70M | 35.80M | 33.43M | 39.75M | 30.56M |
| Net profit | 40.51M | 25.44M | -46.54M | -127.66M | 65.28M | 135.66M | 90.86M | 109.49M |
| Basic EPS | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.16 | 0.09 | -0.21 | -0.67 | 0.21 | 0.48 | 0.30 | 0.38 |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -- | -- | -- | -- | -- | -- |
| Pretax profit | -- | -- | -- | -- | -- | -- |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -- | -- | -- | -- | -- | -- |
| Basic EPS | -- | -- | -- | -- | -- | -- |
| Diluted EPS | -- | -- | -- | -- | -- | -- |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.37B | 1.25B | 1.24B | 1.38B | 1.29B | 1.29B | 1.21B | 1.19B |
| Cash & ST investments | 763.21M | 595.06M | 667.45M | 800.17M | 572.99M | 387.03M | 296.13M | 297.30M |
| Inventory | 314.36M | 314.59M | 321.47M | 338.48M | 410.85M | 522.59M | 521.02M | 506.90M |
| Total assets | 2.79B | 2.64B | 2.42B | 2.46B | 2.43B | 2.77B | 2.83B | 2.83B |
| Total current liabilities | 648.53M | 607.38M | 535.45M | 702.32M | 866.98M | 1.01B | 852.89M | 750.39M |
| Short-term debt | 248.11M | 208.55M | 198.87M | 263.94M | 397.63M | 411.98M | 320.12M | 225.00M |
| Long-term debt | 619.95M | 518.55M | 563.01M | 471.65M | 184.88M | 113.29M | 196.40M | 162.12M |
| Total liabilities | 2,068,505,000.00 | 1,909,643,000.00 | 1,770,020,000.00 | 1,813,420,000.00 | 1,694,406,000.00 | 1,866,115,000.00 | 1,851,086,000.00 | 1,735,627,000.00 |
| Total equity | 725.49M | 729.75M | 645.03M | 644.30M | 732.32M | 900.90M | 982.89M | 1.10B |
| Retained earnings | 936.56M | 944.49M | 893.24M | 498.59M | 528.32M | 618.85M | 668.73M | 739.63M |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.29B | 1.23B | 1.21B | 1.14B | 1.19B | 1.20B |
| Cash & ST investments | 387.03M | 324.51M | 296.13M | 230.97M | 297.30M | 298.03M |
| Inventory | 522.59M | 540.79M | 521.02M | 505.68M | 506.90M | 544.74M |
| Total assets | 2.77B | 2.78B | 2.83B | 2.73B | 2.83B | 3.09B |
| Total current liabilities | 1.01B | 871.53M | 852.89M | 801.75M | 750.39M | 816.43M |
| Short-term debt | 411.98M | 301.52M | 320.12M | 305.73M | 225.00M | 243.15M |
| Long-term debt | 113.29M | 218.13M | 196.40M | 174.42M | 162.12M | 128.14M |
| Total liabilities | 1,866,115,000.00 | 1,867,094,000.00 | 1,851,086,000.00 | 1,774,803,000.00 | 1,735,627,000.00 | 1,977,968,000.00 |
| Total equity | 900.90M | 914.21M | 982.89M | 952.44M | 1.10B | 1.11B |
| Retained earnings | 618.85M | 619.50M | 668.73M | 683.99M | 739.63M | 731.00M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 192.77M | 174.12M | 70.91M | 281.16M | 146.40M | 275.38M | 279.13M | 335.56M |
| Depreciation & amortization | 160.59M | 177.07M | 166.21M | 154.20M | 173.52M | 194.95M | 235.95M | 259.92M |
| Free cash flow | 132.67M | 114.62M | 31.75M | 186.83M | 73.10M | 197.51M | 153.60M | 232.66M |
| Dividends paid | -14.65M | 0 | 0 | -102.00K | -21.85M | -25.03M | -30.29M | -30.49M |
| Stock buybacks / issuance | 2.45M | -94.00K | -945.00K | 193.08M | 14.31M | 3.65M | 0 | 107.22M |
| Ending cash balance | 218.33M | 210.63M | 317.29M | 459.79M | 254.32M | 296.28M | 219.13M | 220.12M |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -- | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -- | -- | -- | -- | -- | -- |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | -- | -- | -- | -- | -- | -- |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 5.46 | 3.15 | -7.84 | -22.61 | 8.04 | 16.00 | 8.78 | 10.13 |
| ROA %i | 1.35 | 0.80 | -2.00 | -5.58 | 2.11 | 4.68 | 2.75 | 3.48 |
| ROIC %i | 2.26 | 1.62 | -2.37 | -7.63 | 3.72 | 8.39 | 5.43 | 6.47 |
| 5-year avg ROE %i | -- | -- | -- | -- | -2.76 | -0.65 | 0.47 | 4.07 |
| EBIT margin %i | 7.42 | 6.66 | -1.50 | -6.43 | 7.84 | 10.49 | 8.75 | 9.39 |
| FCF / sales %i | 11.22 | 8.67 | 3.13 | 14.46 | 4.90 | 10.37 | 7.89 | 12.14 |
| Current ratioi | 2.12 | 2.05 | 2.31 | 1.97 | 1.48 | 1.27 | 1.41 | 1.59 |
| Quick ratioi | 1.44 | 1.29 | 1.53 | 1.39 | 0.89 | 0.65 | 0.68 | 0.74 |
| Debt / assetsi | 46.93 | 42.92 | 44.58 | 43.41 | 37.69 | 36.01 | 36.53 | 34.49 |
| LT debt / equityi | 153.78 | 134.18 | 145.88 | 133.57 | 76.14 | 69.54 | 78.06 | 73.01 |
| Interest coveragei | 4.92 | 4.69 | -0.93 | -5.97 | 7.31 | 6.51 | 4.29 | 4.50 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 3.00 | 4.15 | 23.35 | 14.63 | 8.69 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | 33.27 | -- | -- | 24.18 |
| FCF CAGR (3Y) %i | -- | -- | -- | 12.09 | -13.92 | 83.91 | -6.32 | 47.10 |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 16.00 | 12.47 | 8.78 | 10.94 | 10.13 | 8.18 |
| ROA %i | 4.68 | 3.69 | 2.75 | 3.45 | 3.48 | 2.70 |
| ROIC %i | 8.39 | 6.30 | 5.43 | 5.93 | 6.47 | 5.79 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 10.49 | 7.89 | 8.75 | 9.71 | 9.39 | 8.20 |
| FCF / sales %i | 10.37 | 9.42 | 7.89 | 7.57 | 12.14 | 13.90 |
| Current ratioi | 1.27 | 1.41 | 1.41 | 1.42 | 1.59 | 1.47 |
| Quick ratioi | 0.65 | 0.66 | 0.68 | 0.59 | 0.74 | 0.64 |
| Debt / assetsi | 36.01 | 36.57 | 36.53 | 37.95 | 34.49 | 37.29 |
| LT debt / equityi | 69.54 | 83.93 | 78.06 | 82.37 | 73.01 | 87.58 |
| Interest coveragei | 6.51 | 10.07 | 4.29 | 5.19 | 4.50 | 3.72 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Zegna is the largest reported line at 71.11% of revenue, across 4 reported segments.
- The next-largest line, Tom Ford Fashion, is a distant second at 16.54% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Zegna71.11%
Tom Ford Fashion16.54%
Thom Browne14.03%
Region
United States25.17%
Europe, the Middle East and Africa23.93%
Greater China Region22.70%
Rest of APAC11.94%
Italy11.74%
Americas4.36%
Other0.16%
Quote time 2026-10-08 04:00:02 · For reference only, not investment advice and not tailored to your situation.